awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40782481-141C5766-3808-4814-A9B2-7A86F91939F6
Q40782481-141C5766-3808-4814-A9B2-7A86F91939F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40782481-141C5766-3808-4814-A9B2-7A86F91939F6
Potential for combined therapy with 348U87, a ribonucleotide reductase inhibitor, and acyclovir as treatment for acyclovir-resistant herpes simplex virus infection.
P2860
Q40782481-141C5766-3808-4814-A9B2-7A86F91939F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40782481-141C5766-3808-4814-A9B2-7A86F91939F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d82e4d1a53473388e033709e252bfa7df8b7281
P2860
Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.